“Subject to testing and corresponding regulatory

Quote:

---

“Subject to testing and corresponding regulatory approvals, we’re targeting a million-bottle launch of Generex CBD HydroHealth Water in 2019,” said Joseph Moscato, Generex President & Chief Executive Officer. “Given the network of pharmacies Generex owns itself, we are confident we can achieve if not exceed our million-bottle launch target.

---

I can see how Generex would want deals like this, since it can be an upsale on the inhouse pharmacy now. However, 1M bottles at what $3/bottle, so $3M sales, maybe a 30% margin, so $900K net. That won't move the needle much and the stock shows no interest in this news so far. Also with a company that is trading at $0.10/share.

But, I assume this is the first in the line of many add ons for the pharmacy business. I guess a little profit on many items is better than no profit on 1 item.

Let's not get distracted from the big picture though. Generex can not lose sight on what they want to achieve for the shareholders. However, with 100+ employees now, they are able to spread their vision without diluting the view at the top. DON'T GET DISTRACTED JOE!

Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.